Christopher J Cheng

Title: Christopher J Cheng: Innovator in Genetic Engineering

Introduction

Christopher J Cheng is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genetic engineering, particularly in the development of innovative technologies for genome editing. With a total of 2 patents, Cheng's work is at the forefront of scientific advancements.

Latest Patents

Cheng's latest patents include "Optimized mRNA encoding CAS9 for use in LNPs." This patent relates to novel lipid nanoparticle (LNP)-based compositions that are useful for delivering site-specific endonucleases or nucleic acid molecules into target cells. The invention outlines methods for editing the genome of a cell by utilizing LNP compositions. Another significant patent is "RNA-programmable endonuclease systems and uses thereof." This invention focuses on systems for targeting, editing, or manipulating DNA in a cell using synthetic RNA-guided nucleases (sRGNs) derived from type II CRISPR Cas9 endonucleases.

Career Highlights

Throughout his career, Cheng has worked with notable companies such as Crispr Therapeutics AG and Bayer Healthcare LLC. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of genetic engineering.

Collaborations

Cheng has collaborated with esteemed colleagues, including Andre Cohnen and Moritz Schmidt. These partnerships have further enhanced his innovative work and expanded the impact of his inventions.

Conclusion

Christopher J Cheng is a key figure in the realm of genetic engineering, with a focus on developing advanced technologies for genome editing. His patents and collaborations reflect his commitment to pushing the boundaries of scientific research.